Clinical and molecular characterization of Korean children with infantile and late-onset Pompe disease: 10 years of experience with enzyme replacement therapy at a single center
Min-Sun Kim (Kim MS), Ari Song (Song A), Minji Im (Im M), June Huh (Huh J), I-Seok Kang (Kang IS), Jinyoung Song (Song J), Aram Yang (Yang A), Jinsup Kim (Kim J), Eun-Kyung Kwon (Kwon EK), Eu-Jin Choi (Choi EJ), Sun-Ju Han (Han SJ), Hyung-Doo Park (Park HD), Sung Yoon Cho (Cho SY), Dong-Kyu Jin (Jin DK)
Clin Exp Pediatr. 2019;62(6):224-234.   Published online 2018 Oct 4     DOI:
Citations to this article as recorded by Crossref logo
Two Approaches for a Genetic Analysis of Pompe Disease: A Literature Review of Patients with Pompe Disease and Analysis Based on Genomic Data from the General Population
Kyung-Sun Park
Children.2021; 8(7): 601.     CrossRef
The Novel Compound Heterozygous Mutations of GAA Gene in Mainland Chinese Patient with Classic Infantile-Onset Pompe Disease
Jiaming Li, Yinghua Cui, Xin Wang, Qinglei Wang, Hongjun Wang, Bo Yan
International Heart Journal.2020; 61(1): 178.     CrossRef
Considerations for evaluating the effectiveness and long-term outcome of enzyme replacement therapy in Pompe disease
Chong Kun Cheon
Clinical and Experimental Pediatrics.2020; 63(1): 14.     CrossRef